contributes to T lymphocyte apoptosis during sepsis



* Department of Biochemistry I, University Hospital, Johann Wolfgang Goethe-University Frankfurt, Germany;
Department of Anesthesiology, Molecular Cardioprotection and Inflammation Group, Faculty of Medicine, University of Düsseldorf, Germany;
Department of Medicine IV-Experimental Division, Faculty of Medicine, University of Erlangen-Nürnberg, Erlangen, Germany; and
Westpfalz-Klinikum Kaiserslautern, Department of Internal Medicine I, Germany
1 Correspondence: Department of Biochemistry I, University Hospital, Johann Wolfgang Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. E-mail: v_knethen{at}zbc.kgu.de
In the last two decades, extensive research failed to significantly improve the outcome of patients with sepsis. In part, this drawback is based on a gap in our knowledge about molecular mechanisms understanding the pathogenesis of sepsis. During sepsis, T cells are usually depleted. Recent studies in mice and human cells suggested a role of the peroxisome proliferator-activated receptor
(PPAR
) in provoking apoptosis in activated T lymphocytes. Therefore, we studied whether expression/activation of PPAR
might contribute to T cell death during sepsis. We observed PPAR
up-regulation in T cells of septic patients. In contrast to controls, PPAR
expressing cells from septic patients responded with apoptosis when exposed to PPAR
agonists. Cell demise was attenuated by SR-202, a synthetic PPAR
antagonist, and specificity was further verified by excluding a proapoptotic response to a PPAR
agonist. We propose that up-regulation of PPAR
sensitizes T cells of septic patients to undergo apoptosis. PPAR
activation in T cells requires an exogenous PPAR
agonist, which we identified in sera of septic patients. Septic sera were used to study reporter gene expression containing a PPAR-responsive element. We conclude that PPAR
plays a significant role in T cell apoptosis, contributing to lymphocyte loss in sepsis. Thus, inhibition of PPAR
may turn out to be beneficial for patients suffering from lymphopenia during sepsis.
Key Words: cell death bacterial inflammation leukopenia
This article has been cited by other articles:
![]() |
R. C. Reddy, V. R. Narala, V. G. Keshamouni, J. E. Milam, M. W. Newstead, and T. J. Standiford Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma} Blood, November 15, 2008; 112(10): 4250 - 4258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Soller, S. Drose, U. Brandt, B. Brune, and A. von Knethen Mechanism of Thiazolidinedione-Dependent Cell Death in Jurkat T Cells Mol. Pharmacol., June 1, 2007; 71(6): 1535 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Jo, C. Yang, Q. Miao, M. Marzec, M. A. Wasik, P. Lu, and Y. L. Wang Peroxisome Proliferator-Activated Receptor {gamma} Promotes Lymphocyte Survival through Its Actions on Cellular Metabolic Activities J. Immunol., September 15, 2006; 177(6): 3737 - 3745. [Abstract] [Full Text] [PDF] |
||||